Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association.

Abstract in brief

• The scientific statement discusses the management of severe forms of venous thromboembolism (VTE), including massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension, highlighting the need for practical guidelines amid limited data on some advanced treatments.
• It emphasizes that while evidence-based guidelines exist for acute and chronic VTE, clinicians often face situations where optimal treatment strategies, especially involving thrombolysis and catheter-based interventions, remain uncertain; thus, individualized decision-making is crucial.
• The document aims to help healthcare providers make informed treatment choices considering patient preferences, quality of life, age, and other health conditions, recognizing that management should be tailored to each patient's specific circumstances.]